COVID-19: Where we Started and Where we Stand

The Battle Against COVID-19: Where Do We Stand Now?

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

Adhesive small bowel obstruction: where do we stand now?

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challeng...

Turing's Theory of Morphogenesis: Where We Started, Where We Are and Where We Want to Go

Over 60 years have passed since Alan Turing first postulated a mechanism for biological pattern formation. Although Turing did not have the chance to extend his theories before his unfortunate death two years later, his work has not gone unnoticed. Indeed, many researchers have since taken up the gauntlet and extended his revolutionary and counter-intuitive ideas. Here, we reproduce the basics ...